Recent progress of ferroptosis in cancers and drug discovery

Xiang Wang1, Xinxin Ren2,3,4, Xu Lin5

  • 1Department of Pharmacy, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou 310006, China.

Insights

Ferroptosis, an iron-dependent cell death, inhibits cancer proliferation. Targeting ferroptosis with inducers like erastin offers synergistic effects with anticancer drugs for improved patient prognosis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Ferroptosis is a regulated form of cell death dependent on iron and lipid peroxidation.
  • This cell death pathway is implicated in various diseases, notably cancer.
  • Ferroptosis plays a critical role in suppressing tumor cell growth.

Purpose of the Study:

  • To elucidate the molecular mechanisms and characteristics of ferroptosis.
  • To review the multifaceted roles of ferroptosis in cancer development and therapeutic strategies.
  • To explore the potential of ferroptosis in cancer prognosis prediction and novel drug discovery.

Main Methods:

  • Literature review of ferroptosis research.
  • Analysis of molecular pathways involved in ferroptosis induction.
  • Examination of studies on ferroptosis inducers and their combination therapies.

Main Results:

  • Ferroptosis induction effectively inhibits cancer cell proliferation.
  • Small-molecule ferroptosis inducers (e.g., erastin, RSL3, FIN56) show promise.
  • Combination therapy with ferroptosis inducers and anticancer drugs yields synergistic effects and improves patient outcomes.

Conclusions:

  • Understanding ferroptosis is crucial for advancing cancer treatment.
  • Targeting ferroptosis presents a promising avenue for novel cancer therapies and drug development.
  • Ferroptosis modulation holds potential for predicting patient prognosis.